Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 7

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 7
---
 Company’s independent registered public accounting firm for the year ending December 31, 2025. The affirmative vote of a majority of the votes cast affirmatively or negatively for this proposal willbe required to ratify the selection of Withum. Abstentions will have no effect on the results of the vote on Proposal No. 2. Brokerage firms have authority to vote customers’ unvoted shares held by the firms in street name on this proposal. If a broker does not exercise this authority, such broker non-votes will haveno effect on Proposal No. 2.

Proposal No. 3.Stockholders may vote “FOR” or “AGAINST” or may “ABSTAIN” on Proposal No. 3 to approve, by a non-binding advisory vote, the 2024 compensation for the Company’s Named Executive Officers. The affirmative vote of a majority of the votes cast affirmatively or negatively for this proposalwill be required to ratify the 2024 compensation for the Company’s executive officers. Abstentions will have no effect on the results of the vote on Proposal No. 3. Brokerage firms do not have authority to vote customers’ unvoted shares held by the firms in street name on this proposal.Broker non-votes will have no effect on Proposal No. 3.

Proposal No. 4. Stockholders may
vote “FOR” or “AGAINST” or may “ABSTAIN” on Proposal No. 4 to approve the Issuance Proposal to approve
the issuance of shares of our common stock underlying certain warrants issued by us. The affirmative vote of a majority of the votes
cast affirmatively or negatively for this proposal will be required to approve the Issuance Proposal. Abstentions will have no effect
on the results of the vote on Proposal No. 4. Brokerage firms do not have authority to vote customers’ unvoted shares held by the
firms in street name on this proposal. Broker non-votes will have no effect on Proposal No. 4.

Proposal No. 5. Stockholders may vote “FOR” or “AGAINST” or may “ABSTAIN” on the Authorized Share Increase proposal to amend the Company’s Amended and Restated Certificate of Incorporation to increase the number of our authorized shares of common stock from 112,500,000 shares to 350,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock. The affirmative vote of a majority of